<DOC>
	<DOCNO>NCT00789152</DOCNO>
	<brief_summary>This study measure ability desloratadine levocetirizine decrease nasal obstruction subject study-induced allergic rhinitis . Study participant allergic rhinitis symptom induce Vienna Challenge Chamber receive desloratadine levocetirizine 8 day . After least 10 35-day washout period ( time drug give ) , subject receive opposite treatment 8 day . Subjects total nasal symptom measured.on 8th day treatment period .</brief_summary>
	<brief_title>The Effect Desloratadine Levocetirizine Nasal Obstruction ( Study P03609 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Nasal Obstruction</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>18 45 year age Were free clinically significant disease would interfere study evaluation . Demonstrated hypersensitivity grass allergen use chamber unless confirm previously within 12 month . Hypersensitivity allergen document positive response skin prick test wheal diameter least 3 mm large diluent control radioallergosorbent test ( RAST ) class &gt; =2 ( rating scale 0 6 ) . Had history SAR least 2 year , diagnose investigator , another physician , subjectprovided history . Reported show therapeutic efficacy previous use antihistamine ( without decongestant ) . At screen allergen provocation , subject nasal obstruction symptom severity score least moderate ( &gt; =2 ) decrease baseline nasal airflow ( mL/sec ) measure rhinomanometry &gt; =30 % within 2 hour allergen exposure . Also , subject nasal obstruction symptom severity score none mild ( &lt; =1 ) prior exposure allergen . Women pregnant nursing . Had body mass index ( BMI ) &gt; =30 kg/m^2 . Had asthma ; treat inhaled oral corticosteroid , chromones , theophylline , leukotriene inhibitor , shortacting inhaled Î²2agonists ( except immediately allergen exposure ) ; could go washout period entire study without need medication . Developed wheeze dyspnea screen allergen exposure . Had respiratory infection 4 week prior predose evaluation . Had clinically significant deviation normal physical examination , investigator 's judgment , could interfere study evaluation affect subject safety . Had history laboratory evidence hepatic failure renal failure glomerular filtration rate ( GFR ) know &lt; 30 mL/min . Had know potential hypersensitivity , allergic , idiosyncratic reaction study drug excipients . Had nasal structural abnormality , include large nasal polyp mark septum deviation , significantly interfere nasal airflow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>